MY101902A - Novel galenical retard form - Google Patents

Novel galenical retard form

Info

Publication number
MY101902A
MY101902A MYPI87001977A MYPI19871977A MY101902A MY 101902 A MY101902 A MY 101902A MY PI87001977 A MYPI87001977 A MY PI87001977A MY PI19871977 A MYPI19871977 A MY PI19871977A MY 101902 A MY101902 A MY 101902A
Authority
MY
Malaysia
Prior art keywords
active agent
matrix
percent
retard form
weight
Prior art date
Application number
MYPI87001977A
Inventor
Hans Peter Bier Dr
Jean Claude Gfeller Dr
Czarnecki Wolfgang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB8514855A external-priority patent/GB2160100B/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY101902A publication Critical patent/MY101902A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SOLID DISPERSION OF A PHARMACOLOGICALLY ACTIVE AGENT IN A CRYSTALLINE MATRIX AS A CARRIER, CHARACTERIZED BY AN AGENT WHICH: (A)HAS A SOLUBILITY OF MAXIMALLY 0.01% AT 37?C IN WATER.(B)IS PRESENT IN THE MATRIX AT A TOTAL CONCENTRATION OF MORE THAN 5 PERCENT OF WEIGHT,(C)IS PRESENT IN THE MATRIX AT A CONCENTRATION OF ABOVE 5 PERCENT BY WEIGHT IN A COHERENT CRYSTALLINE FORM.THE SECONDARY ACTIVE AGENT STRUCTURE WHICH RESULTS BY EXTRACTING THE MATRIX MATERIAL WITH E.G. WATER.THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SOLID DISPERSION OR THE SECONDARY ACTIVE AGENT STRUCTURE, WHICH WHEN TAKEN ORALLY, SHOW A SLOW RELEASE OF THE ACTIVE AGENT.
MYPI87001977A 1984-06-14 1987-09-26 Novel galenical retard form MY101902A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22
GB8514855A GB2160100B (en) 1984-06-14 1985-06-12 Novel galenical retard form

Publications (1)

Publication Number Publication Date
MY101902A true MY101902A (en) 1992-02-15

Family

ID=27192063

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001977A MY101902A (en) 1984-06-14 1987-09-26 Novel galenical retard form

Country Status (2)

Country Link
MY (1) MY101902A (en)
SG (1) SG15492G (en)

Also Published As

Publication number Publication date
SG15492G (en) 1992-04-16

Similar Documents

Publication Publication Date Title
HK25192A (en) Novel galenical retard form
ES8500739A1 (en) Extended action controlled release compositions.
SE7407913L (en)
DE3362784D1 (en) Process for preparing free-flowing ethylcellulose microcapsules
CA2054189A1 (en) Stable ascorbic acid compositions
AU6930591A (en) Method for inhibiting aging
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
Chudapongse et al. Mechanism of the inhibitory action of capsaicin on energy metabolism by rat liver mitochondria
JPS57136596A (en) Carcinostatic substance tf-240, its preparation, and carcinostatic agent containing the same
MY101902A (en) Novel galenical retard form
CA2016470A1 (en) Pharmaceutical preparation and method of treatment for liver dysfunction
JPS5215549A (en) Stabilized polyurethane compositions
GB1525971A (en) Deodorant composition
JPS5215548A (en) Stabilized polyurethane elastomer compositions
GB1393427A (en) Rodenticides and process for their preparation
DE3277731D1 (en) Solid, strong alcaline compounds that contain active chlorine
JPS5413512A (en) Liquid detergent compositions and production thereof
JPS5726587A (en) Stabilization of ascorbic acid oxidase
JPS5420195A (en) Preparation of guanosine-5'-monophosphoric acid
ES8500897A1 (en) Amine oxide formulations.
JPS5420090A (en) Separation of acrylic acid hydrazide high polymer
JPS5517347A (en) Production of poultice with high water content
GEP19960331B (en) Herbicidal Composition
JPS5668611A (en) Novel antiallergic agent
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof